About The Cancer
Prostate Cancer is cancer of the prostate gland. It is the most common cancer in men, occurring in about 1 in 6 men. About 200,000 cases are diagnosed annually in the United States. It is usually affects men in their 50s-70s, but can occur earlier in high risk groups. Risk factors include family history of prostate cancer and African American race. Most men do not have any symptoms and are diagnosed based on a blood test done for prostate cancer screening called a PSA (prostate specific antigen). PSA screening usually begins around age 55 in men of average risk, but may be offered to high risk men at age 40-45. Due to the high prevalence of PSA screening in the United States, the majority of prostate cancer cases are diagnosed at an early stage and have a high probability of cure with early treatment. Prostate cancer is not diagnosed by PSA alone, but involves undergoing an office-based biopsy to examine tissue and determine if there are abnormal cancer cells present. Once diagnosed, treatment options include surgery, radiation, and androgen deprivation therapy (reduction of the body’s testosterone level to combat the cancer). The specific treatment choice is determined by a man’s age, medical problems, and the stage and grade of the cancer.
What We Offer
Given better understanding about the low risk of disease progression and the overtreatment of low-grade prostate cancer, the Urologic Oncology specialists at GW understand the role of closely watching this disease rather than having treatment right away. This approach is called Active Surveillance and has been shown in multiple clinical trials to be safe and effective, while avoiding the side effects of more traditional treatments like surgery and radiation therapy. So, just because prostate cancer may be diagnosed, it does not automatically mean that it must be treated.
The GW Cancer Center will provide you information to guide you in deciding which treatment pathway that is right for you. We offer the latest technologies to ensure superlative treatment of prostate cancer including UroNav MRI-ultrasound fusion biopsy, genomic and molecular testing of prostate biopsy tissue (see Specialized Cancer Screening below), DaVinci robotic surgery, intensity-modulated radiotherapy, and cryotherapy.
For those patients with advanced or metastatic disease or those who have failed conventional treatment, we utilize the latest proven combinations of androgen deprivation therapy, new generation anti-androgen agents, androgen synthesis inhibitors, and early chemotherapy to maximize the potential for achieving a durable treatment response. We also offer the opportunity to enroll in clinical trials to benefit from the latest developments in the field. The treatment team uses a multidisciplinary approach involving Urologists, Medical Oncologists, Radiation Oncologists, and specialized Nurses to help you navigate the process. Genetic counselors are also available to provide genetic testing to patients with strong family history of prostate cancer.
Prostate Cancer Information Resources for Patients & their Families
Clinical Trials Information
Prostate Cancer is treated within the GW Urological Oncology Program
- Multi-Disciplinary, Patient Centered Cancer Care
The GW Cancer Center offers advanced treatment in urology, including minimally invasive, laparoscopic surgery for the management of urinary, prostate, kidney, and pelvic disorders.
Urological Oncology Program Information
Free Prostate Cancer Screenings
Men between the ages of 40 and 70, without a history of prostate cancer, can receive a FREE prostate cancer screening, including a digital rectal exam and Prostate-Specific Antigen (PSA) blood test.
Date and Time: Offered the THIRD Friday of every month from 8:30 a.m to 11:30 a.m. by appointment.
Location: MFA Ambulatory Care Center, 22nd and I Streets, NW, Washington, DC 20037. One block from the Foggy Bottom Metro (Blue and Orange Lines)
Limited Availability. Register Today.
To schedule an appointment for a FREE prostate cancer screening, call 202-741-3106. Click here for more information and a printer-friendly information sheet.
The da Vinci® Surgical System
Robotic Prostatectomy a minimally invasive method of removing the prostate gland through advancements in robotics and computer technology. Using the the da Vinci robot, surgeons have more precision which lowers the risk of incontinence and impotence for patients when compared to standard prostate cancer surgery. More prostate cancer surgeries, using the da Vinci robot, are performed at The George Washington University Hospital, a partner of the GW Cancer Center, than at any other hospital in the region.
Specialized Cancer Screening, Genomic Testing, & Imaging offered at the GWU MFA:
Prostate CancerPrior to Prostate Biopsy
- 4KScore blood test - http://4kscore.com/
- Prostate Health Index (PHI) blood test - http://prostatehealthindex.us/
- SelectMDx tissue test - http://mdxhealth.com/selectmdx-prostate-cancer
During Prostate Biopsy
- UroNav MRI-Ultrasound Fusion biopsy - http://www.invivocorp.com/solutions/prostate-solutions/uronav/
After Prostate Biopsy
- ConfirmMDx - http://mdxhealth.com/confirmmdx-prostate-cancer
- Oncotype DX - http://www.genomichealth.com/en-US/oncotype_iq_products/oncotype_dx/oncotype_dx_prostate_cancer
- Decipher - http://deciphertest.com/
- Cysview® Blue Light cystoscopy - https://www.cysview.com/blue-light-cystoscopy-with-cysview-2/what-is-blue-light-cystoscopy-with-cysview/
Other Helpful Resources
Cancer Information Resources for Patients & their Families
- Urology Care Foundation: www.urologyhealth.org
- Prostate Cancer Foundation: www.pcf.org
- Bladder Cancer Advocacy Network (BCAN): www.bcan.org
- American Cancer Society: http://www.cancer.org/cancer/index
Clinical Trials Information